Longevity Evidence Lab Human evidence, uncertainty intact
Research interpretation, not diagnosis or personal treatment advice. Urgent symptoms belong with a clinician, not a browser tab.
Home / Evidence / Leucine
Protein and muscle ageing

Leucine

Useful as part of protein strategy in selected older adults; isolated leucine is not a longevity treatment.

The 30-second verdict Leucine is an essential amino acid and a potent signal for muscle protein synthesis. Leucine-enriched protein can help some older or sarcopenic adults, especially alongside resistance training and adequate total protein. Isolated supplementation cannot substitute for training, total protein, energy intake or treatment of underlying illness.

Evidence matrix

These scores describe different evidence domains. A strong mechanism cannot compensate for missing human outcomes, and a useful clinical effect need not imply slower biological ageing.

Human clinical outcomes Moderate
Human biomarkers Moderate
Animal lifespan None
Mechanistic plausibility Strong
Safety certainty Moderate
Direct longevity relevance Preliminary

What has been shown in humans?

Trials and reviews suggest benefits for muscle mass or function in selected older populations, often using leucine-enriched whey, vitamin D or complete essential amino acid mixtures. This makes it difficult to attribute every effect to leucine alone.

What remains uncertain?

The people who benefit from isolated leucine, the best meal-level strategy, long-term functional outcomes and value in already protein-replete active adults remain uncertain.

Doses used in research

Descriptive, not prescriptive Research often focuses on leucine-enriched protein meals or essential amino acid mixtures rather than a stand-alone capsule. Study protocols should be interpreted within total daily protein intake.

Safety and interpretation

  • Leucine is part of ordinary dietary protein, but high supplemental intakes are less well studied over long periods.
  • Kidney disease, liver disease, frailty and medically prescribed protein restriction require individual advice.
  • Amino-acid signalling is biologically complex; invoking mTOR alone does not establish either harm or life extension.

Primary sources and evidence reviews

Editorial note

This dossier was last reviewed on 13 July 2026. Ratings can change when larger trials, adverse-event data or better systematic reviews appear. Corrections should alter the page rather than being buried in a social-media thread.